🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

36+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 36 recruiting trials for “hepatitis-delta”

Phase 2, PHASE3RecruitingNCT07454837 ↗

Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

🏥 Mirum Pharmaceuticals, Inc.📍 7 sites📅 Started Feb 2026View details ↗
RecruitingNCT07491848 ↗

Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

🏥 Research Center of Periodontal-Systemic Interactions📍 2 sites📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07298330 ↗

A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

🏥 Mirum Pharmaceuticals, Inc.📍 27 sites📅 Started Jan 2026View details ↗
RecruitingNCT07317011 ↗

"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.

👨‍⚕️ Eleonora Sfreddo, FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS📍 3 sites📅 Started Oct 2025View details ↗
RecruitingNCT07429864 ↗

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

👨‍⚕️ Francesca Romana Ponziani, Fondazione Policlinico A. Gemelli IRCCS📍 1 site📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT07200908 ↗

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

🏥 Mirum Pharmaceuticals, Inc.📍 44 sites📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT07096193 ↗

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

👨‍⚕️ Gilead Study Director, Gilead Sciences📍 8 sites📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT07128550 ↗

A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide

🏥 Vir Biotechnology, Inc.📍 36 sites📅 Started Jul 2025View details ↗
RecruitingNCT07442760 ↗

ePro Diary - HDV ( MACROLIVER )

🏥 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT06889805 ↗

HDV Screening Study

👨‍⚕️ Lai Hung Grace Wong, Chinese University of Hong Kong📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06381453 ↗

Belimumab in Autoimmune Hepatitis

👨‍⚕️ Gideon Hirschfield, MB BChir, PhD, University Health Network, Toronto📍 5 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06455280 ↗

A Study of SIPLIZUMAB in AILD and LT Patients

👨‍⚕️ Elizabeth Verna, MD, Columbia University Irving Medical Center/ New York Presbyterian Hospital📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06504485 ↗

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started Sep 2024View details ↗
Enrolling by InvitationNCT06061341 ↗

TruGraf Liver Gene Expression Serial Test

👨‍⚕️ Jason Wellen, MD, Washington University School of Medicine📍 2 sites📅 Started Aug 2024View details ↗
RecruitingNCT06519162 ↗

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

👨‍⚕️ Hyuksoo Eun, Chungnam National University Hospital📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06397859 ↗

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis

🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06264583 ↗

HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection

👨‍⚕️ Jürgen Rockstroh, MD, University Hospital, Bonn📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06248580 ↗

Find HDV and Determine Its Status in Turkey

👨‍⚕️ Mustafa Kemal Çelen, MD, Dicle University, Medical Faculty, Department of Infectious Diseases📍 2 sites📅 Started Mar 2024View details ↗
RecruitingNCT05936073 ↗

DELTA DESCRIBE: the French Collaborative Project

👨‍⚕️ Véronique Loustaud-Ratti, Pr, University Hospital, Limoges📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05903742 ↗

Standardising Care for Hepatitis Delta in the Netherlands

🏥 Erasmus Medical Center📍 1 site📅 Started Jan 2024View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →